Evaluation of O-[11C]methyl-L-tyrosine and O-[18F]fluoromethyl-L-tyrosine as tumor imaging tracers by PET

Nucl Med Biol. 2004 Feb;31(2):191-8. doi: 10.1016/j.nucmedbio.2003.07.004.

Abstract

We investigated the potential of O-[(11)C]methyl-L-tyrosine and O-[(18) F]fluoromethyl-L-tyrosine as positron-emitting tracers for tumor imaging. The two tracers had similar distribution patterns in rats bearing AH109A hepatoma, with pancreas and, on a lesser extent, AH109A showing the highest uptake. Uptake of both tracers in the AH109A and uptake ratios of AH109A-to-tissues (with the exception of AH109A-to-bone) gradually increased for 60 min. O-[(11)C]methyl-L-tyrosine was metabolically stable, whereas a negligible low amount of metabolites was observed for O-[(18)F]fluoromethyl-L-tyrosine. Both tracers showed the potential for tumor imaging.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / diagnostic imaging*
  • Carcinoma, Hepatocellular / metabolism*
  • Cell Line, Tumor
  • Male
  • Metabolic Clearance Rate
  • Mice
  • Mice, Inbred Strains
  • Organ Specificity
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals / pharmacokinetics
  • Rats
  • Tissue Distribution
  • Tyrosine / analogs & derivatives*
  • Tyrosine / pharmacokinetics*

Substances

  • O-(11C)methyl-L-tyrosine
  • O-(18F)fluoromethyl-L-tyrosine
  • Radiopharmaceuticals
  • Tyrosine